Revolution Medicines (RVMD) Earnings Date & Reports
Get AI intraday signals
A.I. Advisor
published Earnings
RVMD is expected to report earnings to rise 7.45% to -100 cents per share on March 03
Q4'24
Est.
$-1.01
Q3'24
Missed
by $0.05
Q2'24
Missed
by $0.04
Q1'24
Beat
by $0.05
Q4'23
Missed
by $0.29
The last earnings report on November 06 showed earnings per share of -93 cents, missing the estimate of -89 cents. With 1.94M shares outstanding, the current market capitalization sits at 9.27B.
an oncology company, which focused on developing novel targeted therapies and engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment.